ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

ASCO

  • Home
  • ASCO
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Active Clinical Trials
  • Coming Soon
  • From the Co-Chairs
  • Institution Spotlights
  • News in Brief
  • People
  • Special Topics
  • Trial Results
  • All
  • AACR
  • Acute lymphoblastic leukemia (ALL)
  • Acute myeloid leukemia
  • Acute myeloid leukemia (AML)
  • Acute promyelocytic leukemia
  • Adolescents and young adults
  • Advanced melanoma
  • Advanced practice providers
  • Advocacy
  • Anal cancer
  • ARPA-H
  • ASCO
  • Awards
  • AYA cancer
  • B-cell lymphoma
  • Big data
  • Biostatistics
  • Bladder cancer
  • Blood cancer
  • Blood cancers
  • Brain cancer
  • Breast cancer
  • Cancer
  • Cancer care delivery research
  • Cancer control
  • Cancer research
  • Cancer research policy
  • Cancer screening
  • Cancer surveillance
  • Cardiotoxicity
  • CBPF
  • Chemoimmunotherapy
  • Chemotherapy
  • Chronic lymphocytic leukemia
  • Chronic myelogenous leukemia
  • Chronic myeloid leukemia
  • Clinical trial
  • Clinical trials
  • Colorectal cancer
  • Colorectal liver metastases
  • ComboMATCH
  • Comis Symposium
  • Communication
  • Community oncology
  • Cooperative Group cancer research
  • Correlative science
  • COVID-19
  • Data science
  • De-escalation
  • Deep learning
  • DEI
  • Developmental therapeutics
  • Diversity
  • EGFR
  • Engineering
  • Esophagus cancer
  • Ethics
  • Federally-funded cancer research
  • Financial hardship
  • Gallbladder cancer
  • Gastric cancer
  • Gastroesophageal junction cancer
  • GBM
  • Gender equity
  • Genetic testing
  • Genomics
  • Geriatric oncology
  • GI cancer
  • Glioblastoma
  • GM-CSF
  • Green tea catechins
  • Group Meeting
  • GU cancer
  • Head and neck cancer
  • Head and neck squamous cell carcinoma
  • health care
  • Health care administration
  • Health equity
  • Hematology
  • Hepatic arterial infusion
  • HER2-positive breast cancer
  • Hormone therapy
  • Imaging
  • Immune checkpoint inhibitors
  • Immunotherapy
  • In memory
  • Institution Evaluation
  • Just-in-time clinical trials
  • Kidney cancer
  • Language
  • Leadership
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lung inflammation
  • Lymphoblastic lymphoma
  • Lymphoma
  • Mammography
  • Meetings
  • Melanoma
  • Mentorship
  • Mesothelioma
  • Misinformation
  • Multiple myeloma
  • Myelodysplastic neoplasms
  • Myelodysplastic syndromes
  • Myeloid malignancies
  • Myeloma
  • myeloMATCH
  • National Cancer Act
  • Natural language processing
  • NCI
  • NCI-Designated Comprehensive Cancer Centers
  • NCI-MATCH
  • NCORP
  • NCTN Grant
  • Neuroendocrine tumors
  • Non-Hodgkin lymphoma
  • Non-small cell lung cancer
  • NSCLC
  • Older adults
  • Ovarian cancer
  • Pancreatic cancer
  • Pancreatic cyst
  • Pancreatic cysts
  • Pancreatic NETs
  • Pathology
  • Patient registry
  • Patient-reported outcomes
  • Penile cancer
  • Peripheral neuropathy
  • Personalized medicine
  • Personalized screening
  • Pneumonitis
  • Policy
  • Pragmatic clinical trials
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Proteasome inhibitors
  • Public-private partnerships
  • Racism
  • Radiation
  • Radiology
  • Rare disease
  • Real-world data
  • Recurrence
  • Renal cell
  • Renal cell carcinoma
  • Reproductive health
  • Research results
  • Retroperitoneal sarcoma
  • Sarcoma
  • Scholarship
  • Sexuality
  • Side effects
  • Smoking cessation
  • Smoldering multiple myeloma
  • Social determinants of health
  • Social genomics
  • Stomach cancer
  • Survivorship
  • Symptom control
  • Symptom management
  • Symptom science
  • Targeted therapy
  • Throat cancer
  • Thyroid cancer
  • TMIST
  • Tobacco cessation
  • Translational research
  • Urinary tract cancer
  • Vaccination
  • Women in oncology
  • Young investigators
  • All
  • Diane Dragaud
  • ECOG-ACRIN Staff
  • ECOG-ACRIN Staff
October 13, 2022
News in Brief
October 13, 2022
Categories
  • News in Brief

News in Brief, October 2022

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
Do you like it?
0 Read more
June 21, 2022
Dr. O'Dwyer and Dr. Schnall
June 21, 2022
Categories
  • From the Co-Chairs

From the Co-Chairs, June 2022

Reflections on the spring conference season, including highlights from the Spring Group Meeting and ASCO's Annual Meeting
Do you like it?
0 Read more
Prev page
12

Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc